Compare CYTK & FSV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYTK | FSV |
|---|---|---|
| Founded | 1997 | 1988 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 7.2B |
| IPO Year | 2004 | N/A |
| Metric | CYTK | FSV |
|---|---|---|
| Price | $62.51 | $155.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 4 |
| Target Price | $78.94 | ★ $214.25 |
| AVG Volume (30 Days) | ★ 1.7M | 222.6K |
| Earning Date | 11-05-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.71% |
| EPS Growth | N/A | ★ 26.06 |
| EPS | N/A | ★ 3.03 |
| Revenue | $87,211,000.00 | ★ $5,479,473,000.00 |
| Revenue This Year | $361.33 | $6.04 |
| Revenue Next Year | $65.14 | $6.89 |
| P/E Ratio | ★ N/A | $51.19 |
| Revenue Growth | ★ 2609.26 | 11.13 |
| 52 Week Low | $29.31 | $147.23 |
| 52 Week High | $69.33 | $209.66 |
| Indicator | CYTK | FSV |
|---|---|---|
| Relative Strength Index (RSI) | 49.62 | 48.14 |
| Support Level | $59.37 | $147.23 |
| Resistance Level | $63.80 | $155.86 |
| Average True Range (ATR) | 2.56 | 3.15 |
| MACD | -0.44 | 1.00 |
| Stochastic Oscillator | 42.46 | 69.33 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
FirstService Corp operates in two business divisions: FirstService Residential and FirstService Brands. FirstService Residential has service contracts to manage thousands of residential communities, including high-, medium-, and low-rise condominiums and co-operatives. FirstService Brands generates the majority of the company's revenue and provides property services to residential and commercial customers through the following brands: California Closets; Paul Davis Restoration; CertPro Painters; Pillar to Post; Floor Coverings International; College Pro Painters; and Service America. The company earns the majority of its revenue in the United States, with the remaining revenue generated in Canada.